[Use Case] ANDRAL, a tele-expertise platform for on-call experts in haematological cytology

01 October 01 October

Haematological cytology is the branch of biology that covers the study of blood cells.

Practised in general or specialised medical test laboratories, this discipline is at the forefront of treatment for leukaemia and/or lymphoma. Haematological cytology is based on the interpretation of microscope images and specialists in this exacting discipline are becoming increasingly rare.
In response to these needs, the Groupe Francophone d'Hématologie Cellulaire (the Francophone Association for Cellular Haematology, or GFHC) set up the ANDRAL network for tele-expertise in haematological cytology, in partnership with the Collège d'Hématologie des Hôpitaux Généraux (the General Hospitals’ College of Haematology).

Launched in October 2012, ANDRAL is the first operational platform of tele-expertise for laboratories in France. Orange worked together with its partner, Tribvn, to set up this telemedicine solution, which complies with regulatory requirements in terms of data security, traceability and hosting.

Pre-registered users can use a web-portal to ask colleagues from all over France to give their opinion on images that are difficult to interpret. These biologists, called “revisers” work in pairs. Each request “posted” on the portal will receive an opinion following consultation and agreement between the pair. When the user makes their decision, a maximum of 24 hours after submitting their request, they can then draw on the synopsis of the additional opinions of the two specialists they have consulted.

The tool enables each requesting laboratory to obtain two expert opinions in less than 24 hours, from analysis of a file of digital images.

Dr. Grégory Lazarian, medical biologist, Paris-Seine-Saint-Denis University Hospitals
J’utiliI use the ANDRAL platform when I come across cells which I find difficult to identify from a morphological perspective, or which cause me problems from the point of view of biological interpretation or diagnostic classification.
Dr. Grégory Lazarian, medical biologist, Paris-Seine-Saint-Denis University Hospitals


The main benefits of the platform for pathologists’ day-to-day practice are:

  • It enables them to seek the advice of professionally recognised cytological specialists,
  • They receive an expert opinion within a response time which is compatible with urgent medical treatment,
  • They can share knowledge within a framework of ongoing medical training.

This makes it much easier to make a diagnosis.